Global Thorium-229 Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

According to our (Global Info Research) latest study, the global Thorium-229 market size was valued at US$ 34.34 million in 2025 and is forecast to a readjusted size of US$ 64.83 million by 2032 with a CAGR of 9.2% during review period.
In 2025, global Thorium-229 production was approximately 227 grams, with a global average market price of around $147,000 per gram. That year, total global production capacity for Thorium-229 reached 450 grams, and the industry's average gross profit margin stood at 28%. Thorium-229 is an artificial radioactive isotope of thorium with an atomic number of 90 and a mass number of 229. With a half-life of approximately 7,340 years, it is a unique long-lived nuclide among the actinides. Its most significant characteristic is the existence of a nuclear isomer (Thorium-229m, or ²²⁹ᵐTh) with an extremely small energy difference—approximately 8.3 eV—between the ground state and the first excited state. As one of the lowest-energy nuclear excited states known, corresponding to the vacuum ultraviolet range, it is considered a prime candidate for realizing "nuclear clock" technology. Unlike traditional atomic clocks that rely on electronic transitions, a thorium-229 nuclear clock utilizes nuclear transitions as a frequency reference; theoretically, this offers superior resistance to external electromagnetic interference and enhanced long-term stability, making it suitable for next-generation high-precision timekeeping, fundamental physics testing, precision measurement, and quantum technology research. Furthermore, the thorium-229 decay chain yields important alpha-emitting therapeutic nuclides such as actinium-225 (²²⁵Ac), garnering significant interest in the field of radiopharmaceuticals. Due to its extremely low natural abundance, thorium-229 is currently produced primarily via the decay chains of uranium-233 or radium-225, or through nuclear reactions; global supply remains concentrated among a limited number of national laboratories and isotope research institutions.
The upstream sector of the thorium-229 industry chain encompasses uranium-233 stockpiles, nuclear reactors, accelerator facilities, target preparation systems, hot cells, and radiochemical separation equipment. Currently, the primary source of thorium-229 is the decay chain of uranium-233 (²³³U); thorium-229 is gradually produced through the long-term alpha decay of uranium-233, making existing uranium-233 stockpiles—accumulated during historical nuclear fuel cycles—a vital resource base. Production can also be explored via reaction pathways involving heavy nuclides such as plutonium and americium, though these methods present challenges regarding yield, purity, and separation complexity. Although Thorium-229 has a long half-life, its parent isotope is scarce and global resources are limited; consequently, key upstream barriers center on the management of high-value Uranium-233 stockpiles, operations in highly radioactive environments, target irradiation technology, remote handling equipment, and complex actinide separation capabilities. The midstream sector comprises national laboratories, metrology institutes, quantum technology research centers, and radiochemistry platforms responsible for Thorium-229 separation and purification, chemical form conversion, nuclear isomer preparation, and experimental system development. Since Thorium-229 typically co-occurs with actinides such as uranium, radium, and actinium, high-purity separation requires techniques like ion exchange and extraction chromatography (using specialized resins) to effectively manage impurities from daughter isotopes like radium and actinium. Midstream research focuses on two primary directions: first, developing nuclear clock technology based on the low-energy nuclear transition of Thorium-229m—encompassing vacuum ultraviolet (VUV) laser excitation, single-ion trapping, quantum state control, and frequency stability measurements; and second, exploring methods for the stable, long-term supply of alpha-emitting therapeutic radionuclides by utilizing Thorium-229 as a key parent isotope in the Actinium-225 production chain. Recent improvements in the precision of nuclear transition energy measurements and breakthroughs in laser excitation technology have shifted nuclear clock research from the theoretical phase toward experimental validation; however, challenges regarding nuclear state lifetimes, excitation efficiency, ion control, and the engineering of compact systems remain to be addressed. Downstream applications of Thorium-229 span high-precision metrology, quantum technology, fundamental physics research, and nuclear medicine. In metrology, the Thorium-229 nuclear clock is considered a potential successor to optical clocks as the next-generation time-frequency standard, with applications including high-precision navigation, deep-space communication, detection of variations in fundamental constants, gravitational potential measurement, and dark matter detection. Because nuclear transitions are minimally affected by the electron shell, they can theoretically provide a more stable frequency reference than traditional atomic clocks. In nuclear medicine, the Thorium-229 decay chain yields Actinium-225—a therapeutic radionuclide of great interest in the field of Targeted Alpha Therapy (TAT)—which can be utilized to develop radiopharmaceuticals for cancer treatment. Therefore, Thorium-229 may in the future form a dual-value system comprising "nuclear clock technology" and "actinide medical isotopes."
The most significant application of Thorium-229 stems from its unique nuclear isomeric state. With an excitation energy of approximately 8.3 eV—falling within the vacuum ultraviolet (VUV) optical excitation range—this represents one of the lowest-energy nuclear transitions known to date. Unlike traditional atomic clocks that rely on electronic orbital transitions, nuclear clocks based on the Thorium-229 nuclear transition theoretically offer superior frequency stability, greater immunity to electromagnetic interference, and more compact system dimensions. They hold promise for applications in next-generation time-frequency standards, deep-space navigation, precision metrology, fundamental physics experiments, and quantum technologies. In recent years, advancements in the precision measurement of Thorium-229 transition energy, the development of VUV laser technology, and the maturation of single-ion trapping techniques have shifted nuclear clock research from theoretical exploration to experimental validation, prompting global research institutions to increase investment in high-purity Thorium-229 supplies and experimental infrastructure.
The development of the Actinium-225 supply chain and targeted alpha therapy offers a second avenue for Thorium-229 utilization. Thorium-229 occupies a key position in the decay chain of important actinide nuclides; its value as a parent isotope extends beyond nuclear clock research to the supply of medical radioisotopes. Serving as a long-term storable actinide parent, Thorium-229 can support research into alpha-emitting therapeutic nuclides—such as Actinium-225 (^225Ac)—via decay chains or related nuclear technology pathways. As targeted alpha therapy gains traction in treating prostate cancer, neuroendocrine tumors, and hematological malignancies, there is growing global emphasis on the security of supply for high-value alpha-emitting nuclides. Given the limited natural availability of Actinium-225, research institutions are exploring diversified supply systems—including thorium-based, radium-based, and accelerator-driven routes—thereby highlighting the potential strategic value of Thorium-229.
Thorium-229 has an extremely low natural abundance; current supplies are primarily derived from stockpiles accumulated through the long-term decay of Uranium-233. Consequently, production capacity is heavily dependent on historical nuclear material reserves and national-level nuclear facilities. Future industry development will focus on enhancing the utilization efficiency of existing Uranium-233 resources, optimizing actinide separation processes, improving automated hot-cell operational capabilities, and establishing a more stable supply system for research purposes. Meanwhile, as research into nuclear clocks and alpha-particle therapy transitions from the laboratory to engineering-scale application, the market will increasingly require standardized product forms—such as high-purity Thorium-229 solutions, experimental-grade samples, Thorium-229 generator materials, and associated analytical certification services. Given the high value and concentrated demand associated with Thorium-229, future competition will focus not on increasing production volume, but rather on enhancing radionuclide purity, supply stability, and technical service capabilities.
Report Scope
This report is a detailed and comprehensive analysis for global Thorium-229 market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Thorium-229 market size and forecasts, in consumption value ($ Million), sales quantity (Gram), and average selling prices (US$/g), 2021-2032
Global Thorium-229 market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Gram), and average selling prices (US$/g), 2021-2032
Global Thorium-229 market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Gram), and average selling prices (US$/g), 2021-2032
Global Thorium-229 market shares of main players, shipments in revenue ($ Million), sales quantity (Gram), and ASP (US$/g), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Thorium-229
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Thorium-229 market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NIDC(DOE IP), ORNL, RITVERC JSC, TerraPower, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Thorium-229 market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market Segmentation
Market segment by Type
Uranium-233 Decay
Radium-226 Irradiation
Others
Market segment by Nuclear States
Thorium-229 Ground State
Thorium-229 Nuclear Isomer State
Market segment by Product Form
Thorium-229 Radionuclide Solution
Thorium-229 Solid Source
Thorium-229 Ion Beam Source
Others
Market segment by Purity Grade
Nuclear Physics Research Grade
Medical Isotope Research Grade
Metrological Standard Grade
Market segment by Application
Nuclear Clock
Targeted Alpha Therapy
Others
Major players covered
NIDC(DOE IP)
ORNL
RITVERC JSC
TerraPower
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Thorium-229 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Thorium-229, with price, sales quantity, revenue, and global market share of Thorium-229 from 2021 to 2026.
Chapter 3, the Thorium-229 competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Thorium-229 breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Thorium-229 market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Thorium-229.
Chapter 14 and 15, to describe Thorium-229 sales channel, distributors, customers, research findings and conclusion.